124i-fiau
Small moleculeexperimentalImaging agent
Clinical trial activity
3 trials · 2 clinical orgs · 0 marketing orgs
Phase 1
1
Phase 2
2
Phase 3
0
Phase 4
0
Earliest trial started Dec 1, 2010 (NCT01337466)
Timeline
Indications
Mechanism of action
- Unspecified targetRadiopharmaceutical
radiopharmaceutical
Chemistry & pharmacology
- Imaging
- 124-iodine
Oral
No
Parenteral
No
Topical
No
Also known as
- 124i-fiau
- 124i-fiau
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT01764919 | Phase 2 | Apr 1, 2013 | BioMed Valley Discoveries, Inc |
| NCT01705496 | Phase 2 | Aug 1, 2012 | BioMed Valley Discoveries, Inc |
| NCT01337466 | Phase 1 | Dec 1, 2010 | BioMed Valley Discoveries, Inc, LifeBridge Health |
Showing 3 of 3 trials
Page 1 / 1
Organizations
Research & Development (2)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| BioMed Valley Discoveries, Inc | For profit | 3 | 3 | 2 | 2010 |
| LifeBridge Health | Academic/Hospital | 1 | 0 | 1 | 2010 |
2 organizations
Page 1 / 1